TEVA logo

TEVA Cash & Equivalents

Latest reported$3.66B
TEVA Quarterly Cash & Equivalents ($22.40M → $3.66B)
High-resolution chart · PNG

TEVA cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
336,090,000
353,057,000
420,634,000
0
93,409,000
108,247,000
77,177,000
120,400,000
55,900,000
69,800,000
47,100,000
55,800,000
95,300,000
60,900,000
50,900,000
61,200,000
63,400,000
42,400,000
39,900,000
13,800,000
7,900,000
15,400,000
4,600,000
13,100,000
22,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.